Literature DB >> 11867023

Acute retinal necrosis: insights into pathogenesis from the mouse model.

S S Atherton1.   

Abstract

Acute retinal necrosis (ARN) is a relatively rare syndrome that is caused by infection with one of several members of the human herpesvirus family. ARN usually occurs in otherwise healthy patients, although it has also been observed in immunocompromised individuals. It is characterized by retinal vasculitis and haemorrhaging, areas of retinal necrosis, vitreous and aqueous inflammation and optic neuritis. It may affect one or both eyes and frequently results in severely reduced vision or blindness in the affected eye. Results using the mouse model of ARN have provided insight into the pathogenesis of this disease. However, many unanswered questions remain, such as why does only a very small fraction of individuals infected with one or more herpesvirus develop ARN? Increased understanding of the interactions of herpesviruses with T cells and cytokines may enable the development of therapeutic strategies targeted specifically to control viral infection in the eye and/or brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11867023

Source DB:  PubMed          Journal:  Herpes        ISSN: 0969-7667


  13 in total

1.  Intravitreal treatment with antisense oligonucleotides targeting tumor necrosis factor-α in murine herpes simplex virus type 1 retinitis.

Authors:  Rafael S Grajewski; Jin Li; Susanne Wasmuth; Maren Hennig; Dirk Bauer; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-10       Impact factor: 3.117

2.  Role for nectin-1 in herpes simplex virus 1 entry and spread in human retinal pigment epithelial cells.

Authors:  Vaibhav Tiwari; Myung-Jin Oh; Maria Kovacs; Shripaad Y Shukla; Tibor Valyi-Nagy; Deepak Shukla
Journal:  FEBS J       Date:  2008-09-17       Impact factor: 5.542

3.  [Diagnostics and differential diagnosis of acute retinal necrosis].

Authors:  U Pleyer; S Metzner; J Hofmann
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

Review 4.  Herpes simplex virus type 2 mediated acute retinal necrosis in a pediatric population: case series and review.

Authors:  Ruwan A Silva; Audina M Berrocal; Darius M Moshfeghi; Mark S Blumenkranz; Steven Sanislo; Janet L Davis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-05       Impact factor: 3.117

5.  Role of nectin-1, HVEM, and PILR-alpha in HSV-2 entry into human retinal pigment epithelial cells.

Authors:  Shripaad Y Shukla; Yogesh K Singh; Deepak Shukla
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

6.  Virus spread and immune response following anterior chamber inoculation of HSV-1 lacking the Beclin-binding domain (BBD).

Authors:  Ming Zhang; Jason Covar; Nancy Y Zhang; Wen Chen; Brendan Marshall; Juan Mo; Sally S Atherton
Journal:  J Neuroimmunol       Date:  2013-04-21       Impact factor: 3.478

7.  Infiltrating cells and IFNgamma production in the injected eye after uniocular anterior chamber inoculation of HSV-1.

Authors:  Heather M Cathcart; Mark A Fields; Mei Zheng; Brendan Marshall; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05       Impact factor: 4.799

8.  Neutrophils protect the retina of the injected eye from infection after anterior chamber inoculation of HSV-1 in BALB/c mice.

Authors:  Mei Zheng; Mark A Fields; Yi Liu; Heather Cathcart; Elizabeth Richter; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-16       Impact factor: 4.799

9.  Subconjunctival antisense oligonucleotides targeting TNF-alpha influence immunopathology and viral replication in murine HSV-1 retinitis.

Authors:  Jin Li; Susanne Wasmuth; Dirk Bauer; Hanna Baehler; Maren Hennig; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-20       Impact factor: 3.117

10.  Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck.

Authors:  Elizabeth R Richter; James K Dias; James E Gilbert; Sally S Atherton
Journal:  J Infect Dis       Date:  2009-12-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.